A Resource for Healthcare and Social Services Professionals
November 30, 2020
6:00 pm–8:00 pm ET
This training is part 3 of 8 for the training series that will provide APPs the additional 16 hours to meet the requirements to obtain a MAT Certificate
Advanced Practice Practitioners (APPs) must complete 24 hours of specialized training to obtain a waiver to prescribe buprenorphine—an eight-hour MAT waiver training course plus an additional 16 hours of training. Until now, the additional 16 hours has primarily been available through online, pre-recorded modules.
Boston Medical Center’s OBAT TTA is proud to announce a new no-cost, live training series that will provide APPs the additional 16 hours to meet these requirements. This training was developed by and for APPs.
The 2nd session in this series is titled "Medications for OUD and Addressing Polysubstance Use." It i will be offered October 27th from 4pm-6pm ET.
Nurse Practitioners, Certified Nurse Midwifes (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants
Identify the rationale for using medications to treat opioid use disorder
Describe effective medications for treating opioid use disorder
Explain the unique properties of methadone, buprenorphine, and naltrexone
Diagnose and formulate a treatment plan for misuse and use disorders of the following substances: Benzodiazepines, Cocaine and other stimulants, Alcohol, Tobacco and Patients engaging in polysubstance use
Bureau of Substance Addiction Services (DPH/BSAS), Providers Clinical Support System (PCSS), and Boston Medical Center Office Based Addiction Treatment and Technical Assistance (BMC OBAT TTA).